Influence of Donor C3 Allotype on Late Renal-Transplantation Outcome
Katherine M. Brown, M.Sc., Elli Kondeatis, M.D., Ph.D., Robert W. Vaughan, Ph.D., Sui P. Kon, M.D., Ph.D., Christopher K.T. Farmer, M.D., John D. Taylor, M.D., Xiang He, Ph.D., Atholl Johnston, Ph.D., Catherine Horsfield, M.R.C.Path., Bert J.C. Janssen, M.Sc., Piet Gros, Ph.D., Wuding Zhou, M.D., Ph.D., Steven H. Sacks, M.D., Ph.D., and Neil S. Sheerin, M.D., Ph.D.
Background The complement system has a critical role in boththe innate and the adaptive immune responses. In humans, C3exists as two main allotypes, F (fast) and S (slow), which areknown to affect the incidence of inflammatory disease. We conducteda study to address the influence of these alleles on late renal-graftoutcome.
Methods We determined the C3 allotypes of 662 pairs of adultkidney donors and recipients from 1993 through 2002 and thenrelated C3F/S polymorphism status to demographic and clinicaloutcome data. The median length of follow-up was 3.3 years.
Results Analysis of 513 pairs of white donors and recipientsidentified 113 C3S/S recipients of a C3S/F or a C3F/F kidneyand 179 C3S/S recipients of a C3S/S kidney. Graft survival wassignificantly better with a C3F/F or C3F/S donor allotype thana C3S/S allotype (P=0.05). The hazard ratio for graft loss ofC3S/S kidneys, as compared with C3F/F or C3F/S kidneys, was2.21 (95 percent confidence interval, 1.04 to 4.72; P=0.04).The graft function of C3F/F or C3F/S donor kidneys was significantlybetter than that of C3S/S donor kidneys (P<0.001). The effectof the C3F allele was specific to recipients who did not themselvespossess this allele. Multivariate analysis excluded effectsof other factors known to influence graft outcome.
Conclusions Expression of C3 alleles by donor renal cells appearsto have a differential effect on late graft outcome. Among whiteC3S/S recipients, receipt of a C3F/F or C3F/S donor kidney,rather than a C3S/S donor kidney, is associated with a significantlybetter long-term outcome. These findings suggest that the twoalleles have functional differences.
Source Information
From the Department of Nephrology and Transplantation, King's College London, Guy's Hospital, London (K.M.B., J.D.T., W.Z., S.H.S., N.S.S.); the Clinical Transplantation Laboratories, Guy's Hospital, London (E.K., R.W.V.); King's College Hospital, London (S.P.K.); Kent and Canterbury Hospital, Canterbury, United Kingdom (C.K.T.F.); the Department of Clinical Pharmacology, Barts and the London, Queen Mary's School of Medicine and Dentistry, London (X.H., A.J.); the Department of Histopathology, Guy's and St. Thomas' National Health Service Foundation Trust, London (C.H.); and the Department of Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Faculty of Science, Utrecht University, Utrecht, the Netherlands (B.J.C.J., P.G.).
Address reprint requests to Dr. Sheerin at the Department of Nephrology and Transplantation, 5th Fl., Thomas Guy House, Guy's Hospital, London SE1 9RT, United Kingdom, or at neil.sheerin{at}kcl.ac.uk.
Naesens, M., Li, L., Ying, L., Sansanwal, P., Sigdel, T. K., Hsieh, S.-C., Kambham, N., Lerut, E., Salvatierra, O., Butte, A. J., Sarwal, M. M.
(2009). Expression of Complement Components Differs Between Kidney Allografts from Living and Deceased Donors. J. Am. Soc. Nephrol.
20: 1839-1851
[Abstract][Full Text]
Park, K. H., Fridley, B. L., Ryu, E., Tosakulwong, N., Edwards, A. O.
(2009). Complement Component 3 (C3) Haplotypes and Risk of Advanced Age-Related Macular Degeneration. IOVS
50: 3386-3393
[Abstract][Full Text]
Mrug, M., Zhou, J., Mannon, R. B., Naesens, M., Butte, A. J., Sarwal, M. M., Varagunum, M., Opelz, G., Yaqoob, M. M.
(2009). C3 Polymorphisms and Outcomes of Renal Allografts. NEJM
360: 2477-2479
[Full Text]
Varagunam, M., Yaqoob, M. M., Dohler, B., Opelz, G.
(2009). C3 Polymorphisms and Allograft Outcome in Renal Transplantation. NEJM
360: 874-880
[Abstract][Full Text]
Fremeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., Kapur, G., Mattoo, T., Nivet, H., Wong, W., Gie, S., de Ligny, B. H., Fischbach, M., Gupta, R., Hauhart, R., Meunier, V., Loirat, C., Dragon-Durey, M.-A., Fridman, W. H., Janssen, B. J. C., Goodship, T. H. J., Atkinson, J. P.
(2008). Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood
112: 4948-4952
[Abstract][Full Text]
Rerolle, J.-P., Munteanu, E., Drouet, M., Szelag, J.-C., Champtiaux, B., Yagoubi, F., Preux, P.-M., Aldigier, J.-C., Le Meur, Y.
(2008). PAI-1 donor polymorphism influences long-term kidney graft survival. Nephrol Dial Transplant
23: 3325-3332
[Abstract][Full Text]
Sacks, S., Zhou, W.
(2008). New Boundaries for Complement in Renal Disease. J. Am. Soc. Nephrol.
19: 1865-1869
[Abstract][Full Text]
Ansari, M. J., Sayegh, M. H.
(2008). Complement dances with T cells. Blood
112: 1551-1552
[Full Text]
Sheerin, N. S., Risley, P., Abe, K., Tang, Z., Wong, W., Lin, T., Sacks, S. H.
(2008). Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J.
22: 1065-1072
[Abstract][Full Text]
Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., Sacks, S. H., Zhou, W.
(2008). Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood
111: 2452-2461
[Abstract][Full Text]
Roos, A., Daha, M. R., van Pelt, J., Berger, S. P.
(2007). Mannose-binding lectin and the kidney. Nephrol Dial Transplant
22: 3370-3377
[Full Text]
Yates, J. R.W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., Armbrecht, A. M., Dhillon, B., Deary, I. J., Redmond, E., Bird, A. C., Moore, A. T., the Genetic Factors in AMD Study Group,
(2007). Complement C3 Variant and the Risk of Age-Related Macular Degeneration. NEJM
357: 553-561
[Abstract][Full Text]
Berger, S. P., Roos, A., Mallat, M. J.K., Schaapherder, A. F.M., Doxiadis, I. I., van Kooten, C., Dekker, F. W., Daha, M. R., de Fijter, J. W.
(2007). Low Pretransplantation Mannose-Binding Lectin Levels Predict Superior Patient and Graft Survival after Simultaneous Pancreas-Kidney Transplantation. J. Am. Soc. Nephrol.
18: 2416-2422
[Abstract][Full Text]
Dragun, D.
(2006). Complement-ary matching: a definite maybe. Nephrol Dial Transplant
21: 3371-3373
[Full Text]
Soulillou, J.-P., Giral, M.
(2006). Influence of graft characteristics on the outcome of kidney transplantation.. NEJM
354: 2060-2062
[Full Text]